INTEGRATED FILING — GI



General information about company

Scrip code 544286
NSE Symbol NIVABUPA
MSEI Symbol NOTLISTED
ISIN INE995S01015
Name of Company NIVA BUPA HEALTH INSURANCE COMPANY LIMITED
Type of company Main Board
Class of security Equity
Type Of Insurance Non-Linked Policy
Date of start of financial year 01-Apr-2024
Date of end of financial year 31-Mar-2025
Date of board meeting when results were approved 07-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 29-Apr-2025
Description of presentation currency INR (in Actuals)
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Start date and time of board meeting 07-May-2025   16:35:00
End date and time of board meeting 07-May-2025   18:30:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Direct
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Whether the company has any related party? No
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? No
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
(III) Whether the company is a high value debt listed entity according to regulation 15(1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 2024-05-10
Indicate Company website link for updated RPT policy of the Company www.nivabupa.com
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? Yes
No. of times funds raised during the quarter 1
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
No default on loans and Debt securities during the quarter ended March 2025


Format for financial results by general insurance companies filed with stock exchanges
Partiuclars Current Quarter Year to Date Figures
Date of start of reporting period 01-Jan-2025 01-Apr-2024
Date of end of reporting period 31-Mar-2025 31-Mar-2025
Whether accounts are audited or unaudited Audited Audited
Nature of report standalone or consolidated Standalone Standalone
OPERATING RESULTS
1 Operating income
(i) Gross Premiums Written 20786500000 67622300000
(ii) Net Premium written 16721100000 53694300000
(iii) Premium Earned (Net) 15274200000 48944600000
(iv) Income from investments (net) 937800000 2873500000
(v) Other income
1 Other Income 0 0
2 Contribution from the Shareholders' Account 0 0
3 (a) Towards Excess Expenses of Management -569400000 1414300000
4 (b) Towards remuneration of MD/CEO/WTD/Other KMPs 4700000 10200000
5 (c) Others 0 0
Total other income -564700000 1424500000
(vi) Total income 15647300000 53242600000
2 Operating expenses
(i) Commissions & Brokerage (net) 2955000000 10645800000
(ii) Net commission 2955000000 10645800000
(iii) Operating Expenses related to insurance business
(a) Employees remuneration and welfare expenses 1423100000 6634300000
(b) Other operating expenses
0 Advertisement and publicity 924000000 2063800000
1 Other expenses 780200000 2133100000
Total other operating expenses 1704200000 4196900000
(c) Total operating expenses related to insurance business 3127300000 10831200000
(iv) Premium Deficiency 0 0
(v) Incurred Claims
(a) Claims Paid 8245600000 28847300000
(b) Change in Outstanding Claims (incl. IBNR/IBNER) 370000000 1117900000
Total Incurred claims 8615600000 29965200000
(vi) Total Expense 14697900000 51442200000
(vii) Underwriting Profit(Loss) 576300000 -2497600000
(viii) Provisions for doubtful debts (including bad debts written off) 0 0
(ix) Provisions for diminution in value of investments 0 0
(x) Operating Profit/loss: 949400000 1800400000
(xi) Appropriations
(a) Transfer to Profit and Loss A/c 949400000 1800400000
(b) Transfer to reserves 0 0



NON-OPERATING RESULTS
1 Income in shareholder's account
(a) Transfer from Policyholders' Fund 949400000 1800400000
(b) Income from investments 495900000 1924700000
(c) Other income
1 Other income 118900000 129700000
Total other income 118900000 129700000
Total income 1564200000 3854800000
2 Expenses
(i) Expenses other than those related to insurance business -484100000 1713300000
(ii) Provisions for doubtful debts (including bad debts written off) -12500000 6300000
(iii) Provisions for diminution in value of investments 0 0
Total Expense -496600000 1719600000
3 Profit / Loss before extraordinary items
 2060800000 2135200000
4 Extraordinary Items
0 0
5 Profit/ (loss) before tax
 2060800000 2135200000
6 Provision for tax
 0 0
7 Profit / (loss) after tax
 2060800000 2135200000
8 Divident per share
(a) Interim Dividend 0 0
(b) Final dividend 0 0
9 Opening Balance and Approproations from PAT (Net) -9245300000 -9319700000
10 Profit (loss) carried to balance sheet -7184500000 -7184500000
11 Paid up equity capital 18270300000 18270300000
12 Reserve and Surplus (Excluding Revualuation Reserve) 12312900000 12312900000
13 Fair value change account and revaluation reserve -30700000 -30700000
14 Assets
(a) Investments
(i) Shareholders Fund 36199200000 36199200000
(ii) Policyholders' Fund 45551600000 45551600000
Total investments 81750800000 81750800000
(b) Other Assets (Net of current liabilites and provisions) -48673100000 -48673100000
Total assets 33077700000 33077700000



Analytical Ratios
(i) Solvency ratio 3.03 3.03
(ii) Expenses of management ratio 0.3633 0.3922
(iii) Incurred Claim Ratio 0.5641 0.6122
(iv) Net retention ratio 0.8044 0.794
(v) Combined ratio 0.9278 1.0122
(vi) Earning per share
(a) Basic and diluated EPS before extraordinary items (net of tax expense) for the period (not to be annualized) 1.13 1.22
(b) Basic and diluted EPS after extraordinary items (net of tax expense) for the period (not to be annualized) 1.13 1.22
(vii) NPA ratios
(a) Gross NPAs 543000000 543000000
(c) Net NPAs 0 0
(b) Percentage of Gross NPAs 0.0066 0.0066
(d) Percentage of net NPAs 0 0
(viii) Yield on Investments
(a) Without unrealized gains 185000 704000
(b) With unrealised gains 250000 853000
(ix) Public shareholding (in case of public sector insurance companies)
(a) Number of shares 804335928 804335928
(b) Percentage of shareholding 0.4402 0.4402
(c) Percentage of government holding 0 0



Investor Compliants
(i) No of investor complaints pending at the beginning of the period 5 0
(ii) No of investor complaints during the period 14 283
(iii) No of investor complaints disposed off during the period 18 282
(iv) No of investor complaints remaining unresolved at the end of the period 1 1



(c) Notes Format for financial results by general insurance companies filed with stock exchanges
1. Net Premium written is Net of reinsurance (including excess of loss reinsurance). 2. Income from Investments (Net) is Net of amortisation and losses (including capital gains). 3. Commission and Brokerage (Net) is net of commission received on reinsurance cession. 4. Reserves & Surplus (excluding revaluation reserve) is Net of debit balance in Profit & Loss Account. 5. Analytical ratios have been calculated as per definition given in IRDAI analytical ratios disclosures. 5a The Solvency has been computed at the last day of the period. 5b The Expenses of Management has been computed on the basis of Gross Direct Premium. 5c Earning per share figures for the three months ended and year to date ended are not annualised. 5d (a) % of Gross NPA = Gross NPA / Total Investments. (b) % of Net NPA = (Gross NPA - Provision on investments) / (Total Investments - Provision on investments). 5e Yield on investment is computed on average of Opening & Closing Investment. 6 Company had received 283 complaints during the year ended March 31, 2025. Being the first year after listing, all these complaints mainly pertain to non-receipt of refund of IPO Application by Investors (Resident Individuals). Out of 283 complaints, 282 complaints were attended and disposed-off within the year. As on March 31, 2025, only 1 complaint remain unresolved.



Format for financial results by general insurance companies filed with stock exchanges
Partiuclars Current Quarter Year to Date Figures
Date of start of reporting period 01-Jan-2025 01-Apr-2024
Date of end of reporting period 31-Mar-2025 31-Mar-2025
Whether accounts are audited or unaudited Audited Audited
Nature of report standalone or consolidated Standalone Standalone
Segment Income
1 Fire
(i) Net premium 0 0
(ii) Income form investments 0 0
(iii) Other income 0 0
2 Marine
(i) Net premium 0 0
(ii) Income form investments 0 0
(iii) Other income 0 0
3 Health including personal accident
(i) Net premium 15274200000 48944600000
(ii) Income form investments 937800000 2873500000
(iii) Other income -564700000 1424500000
4 Health retail
(i) Net premium 0 0
(ii) Income form investments 0 0
(iii) Other income 0 0
5 Health group
(i) Net premium 0 0
(ii) Income form investments 0 0
(iii) Other income 0 0
6 Health government schemes
(i) Net premium 0 0
(ii) Income form investments 0 0
(iii) Other income 0 0
7 Motor
(i) Net premium 0 0
(ii) Income form investments 0 0
(iii) Other income 0 0
8 Retail
(i) Net premium 0 0
(ii) Income form investments 0 0
(iii) Other income 0 0
9 Group and corporate
(i) Net premium 0 0
(ii) Income form investments 0 0
(iii) Other income 0 0
10 Any other class as may be specified by the Authority. - Enter the name below
(1) Other segment 1
Name of other segment 0
(i) Net premium 0 0
(ii) Income form investments 0 0
(iii) Other income 0 0

Unallocated
(i) Net premium 0 0
(ii) Income form investments 0 0
(iii) Other income 0 0


Notes to the Income
1 Health including Personal accident includes Travel Insurance 2 Income from Investment and Other Income which cannot be allocated to any segment are apportioned on the basis of Gross Direct Premium


Format for financial results by general insurance companies filed with stock exchanges
Partiuclars Current Quarter Year to Date Figures
Date of start of reporting period 01-Jan-2025 01-Apr-2024
Date of end of reporting period 31-Mar-2025 31-Mar-2025
Whether accounts are audited or unaudited Audited Audited
Nature of report standalone or consolidated Standalone Standalone
Segment Premium Deficiency
1 Fire 0 0
2 Marine 0 0
3 Health including personal accident 0 0
4 Health Retail 0 0
5 Health Group 0 0
6 Health Government Schemes 0 0
7 Motor 0 0
8 Retail 0 0
9 Group And Corporate 0 0
10 Any other class as may be specified by the Authority. - Enter the name below
Name of Other Segment
1 0 0 0
2 0 0 0
3 0 0 0
4 0 0 0
5 0 0 0
6 0 0 0
7 0 0 0
8 0 0 0
9 0 0 0
10 0 0 0
11 Unallocated 0 0


Format for financial results by general insurance companies filed with stock exchanges
Partiuclars Current Quarter Year to Date Figures
Date of start of reporting period 01-Jan-2025 01-Apr-2024
Date of end of reporting period 31-Mar-2025 31-Mar-2025
Whether accounts are audited or unaudited Audited Audited
Nature of report standalone or consolidated Standalone Standalone
Segment Underwriting Profit/Loss
1 Fire 0 0
2 Marine 0 0
3 Health including personal accident 576300000 -2497600000
4 Health Retail 0 0
5 Health Group 0 0
6 Health Government Schemes 0 0
7 Motor 0 0
8 Retail 0 0
9 Group And Corporate 0 0
10 Any other class as may be specified by the Authority. - Enter the name below
Name of Other Segment
1 0 0 0
2 0 0 0
3 0 0 0
4 0 0 0
5 0 0 0
6 0 0 0
7 0 0 0
8 0 0 0
9 0 0 0
10 0 0 0
11 Unallocated 0 0

Notes to the Underwriting ProfitLoss
1. Health including Personal accident includes Travel Insurance.


Format for financial results by general insurance companies filed with stock exchanges
Partiuclars Current Quarter Year to Date Figures
Date of start of reporting period 01-Jan-2025 01-Apr-2024
Date of end of reporting period 31-Mar-2025 31-Mar-2025
Whether accounts are audited or unaudited Audited Audited
Nature of report standalone or consolidated Standalone Standalone
Segment Operating Profit/Loss
1 Fire 0 0
2 Marine 0 0
3 Health including personal accident 949400000 1800400000
4 Health Retail 0 0
5 Health Group 0 0
6 Health Government Schemes 0 0
7 Motor 0 0
8 Retail 0 0
9 Group And Corporate 0 0
10 Any other class as may be specified by the Authority. - Enter the name below
Name of Other Segment
1 0 0 0
2 0 0 0
3 0 0 0
4 0 0 0
5 0 0 0
6 0 0 0
7 0 0 0
8 0 0 0
9 0 0 0
10 0 0 0
11 Unallocated 0 0

Notes to the Operating ProfitLoss
1. Health including Personal accident includes Travel Insurance.


Format for financial results by general insurance companies filed with stock exchanges
Partiuclars Current Quarter
Date of start of reporting period 01-Jan-2025
Date of end of reporting period 31-Mar-2025
Whether accounts are audited or unaudited Audited
Nature of report standalone or consolidated Standalone
Segment Technical Liabilities (Unexpired Risk Reserve-Net)
1 Fire 0
2 Marine 0
3 Health including personal accident 26863000000
4 Health Retail 0
5 Health Group 0
6 Health Government Schemes 0
7 Motor 0
8 Retail 0
9 Group And Corporate 0
10 Any other class as may be specified by the Authority. - Enter the name below
Name of Other Segment
1 0 0
2 0 0
3 0 0
4 0 0
5 0 0
6 0 0
7 0 0
8 0 0
9 0 0
10 0 0
11 Unallocated 0

Notes to the Technical Liabilities
1. Health including Personal accident includes Travel Insurance.


Format for financial results by general insurance companies filed with stock exchanges
Partiuclars Current Quarter
Date of start of reporting period 01-Jan-2025
Date of end of reporting period 31-Mar-2025
Whether accounts are audited or unaudited Audited
Nature of report standalone or consolidated Standalone
Segment Technical Liabilities (Unexpired Claims Reserves Including IBNR & IIBNER)
1 Fire 0
2 Marine 0
3 Health including personal accident 5275400000
4 Health Retail 0
5 Health Group 0
6 Health Government Schemes 0
7 Motor 0
8 Retail 0
9 Group And Corporate 0
10 Any other class as may be specified by the Authority. - Enter the name below
Name of Other Segment
1 0 0
2 0 0
3 0 0
4 0 0
5 0 0
6 0 0
7 0 0
8 0 0
9 0 0
10 0 0
11 Unallocated 0

Notes to the Technical Liabilities
1. Health including Personal accident includes Travel Insurance.


Format for financial results by general insurance companies filed with stock exchanges
Partiuclars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2024
Date of end of reporting period 31-Mar-2025
Whether accounts are audited or unaudited Audited
Nature of report standalone or consolidated Standalone
Sources of Funds
1 Share capital 18270300000
2 Reserves and surplus 19497400000
3 Share application money pending allotment 25200000
4 Fair value change account
(a) Policyholders funds 6800000
(b) Shareholders funds -37500000
5 Borrowings 2500000000
6 Minority Interest 0
Total Sources of Funds 40262200000
APPLICATION OF FUNDS
1 Investments shareholders 36199200000
2 Investments policyholders 45551600000
2 Loans 0
3 Fixed assets 752500000
4 Deferred Tax Asset 0
5 Current assets
Cash and bank balances 2203500000
Advances and other assets 12894800000
6 Sub-total (a) 15098300000
7 Current liabilities 37492400000
8 Provisions 27031500000
9 Sub-total (b) 64523900000
10 Net current assets (c) = (a - b) -49425600000
11 Miscellaneous expenditure (to the extent not written off or adjusted) 0
12 Debit balance in profit & loss account (shareholder ' s account) 7184500000
13 Total 40262200000
14 Contigent Liabilities 1944900000



Cash flow statement,direct
Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-Apr-2024
B Date of end of reporting period 31-Mar-2025
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Standalone
Statement of cash flows
Cash flows from used in operating activities
Classes of cash receipts from operating activities
Receipts from sales of goods and rendering of services 0
Receipts from royalties fees, commissions and other revenue 0
Receipts from contracts held for dealing or trading purpose 0
Receipts from premiums and claims annuities and other policy benefits 93464000000
Receipts from rents and subsequent sales of assets held for rental to others and subsequently held for sale 0
Other cash receipts from operating activities 0
Classes of cash payments from operating activities
Payments to suppliers for goods and services 0
Payments from contracts held for dealing or trading purpose 0
Payments to and on behalf of employees 0
Payments for premiums and claims, annuities and other policy benefits 58096500000
Payments to manufacture or acquire assets held for rental to others and subsequently held for sale 0
Other cash payments from operating activities 18689600000
Net cash flows from (used in) operations 16677900000
Dividends received 0
Interest paid 0
Interest received 0
Income taxes paid (refund) 0
Other inflows (outflows) of cash -136300000
Net cash flows from (used in) operating activities 16541600000
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0
Cash flows used in obtaining control of subsidiaries or other businesses 0
Other cash receipts from sales of equity or debt instruments of other entities 33089100000
Other cash payments to acquire equity or debt instruments of other entities 59927900000
Other cash receipts from sales of interests in joint ventures 0
Other cash payments to acquire interests in joint ventures 0
Proceeds from sales of property, plant and equipment 5600000
Purchase of property, plant and equipment 414200000
Proceeds from sales of investment property 0
Purchase of investment property 0
Proceeds from sales of goodwill 0
Purchase of goodwill 0
Proceeds from sales of intangible assets 0
Purchase of intangible assets 0
Proceeds from biological assets other than bearer plants 0
Purchase of biological assets other than bearer plants 0
Proceeds from sales of other long-term assets 0
Purchase of other long-term assets 0
Cash advances and loans made to other parties 0
Cash receipts from repayment of advances and loans made to other parties 0
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0
Dividends received 0
Interest received 3772900000
Income taxes paid (refund) 0
Other inflows (outflows) of cash -1500000
Proceeds from government grants 0
Net cash flows from (used in) investing activities -23476000000
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries that do not result in loss of control 0
Payments from changes in ownership interests in subsidiaries that do not result in loss of control 0
Proceeds from issuing shares 7977400000
Proceeds from issuing other equity instruments 0
Payments to acquire or redeem entity's shares 0
Payments of other equity instruments 0
Proceeds from exercise of stock options 0
Proceeds from issuing debentures notes bonds etc 0
Proceeds from borrowings 0
Repayments of borrowings 0
Payments of lease liabilities 0
Dividends paid 0
Interest paid 267500000
Income taxes paid (refund) 0
Other inflows (outflows) of cash -200000
Net cash flows from (used in) financing activities 7709700000
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 775300000
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0
Net increase (decrease) in cash and cash equivalents 775300000
Cash and cash equivalents cash flow statement at beginning of period 1428200000
Cash and cash equivalents cash flow statement at end of period 2203500000



Details of Impact of Audit Qualification
Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 S R Batliboi and Co LLPnChartered Accountants Yes 31-Jul-2025
2 T R Chadha and Co LLPnChartered Accountants Yes 30-Sep-2025


Signatories details

Name of CEO / Managing director
Name of audit committee chairman
Name of statutory auditor
Name of other signatory, if any, with designation
Place
Date


Statement on Deviation or Variation for proceeds of Public Issue, Rights Issue, Preferential Issue, Qualified Institutions Placement Etc. (1)
Mode of Fund Raising Public Issues
Description of mode of fund raising (Applicable in case of others is selected)
Date of Raising Funds 12-Nov-2024
Amount Raised 8000000000
Report filed for Quarter ended 31-Mar-2025
Monitoring Agency Not Applicable
Monitoring Agency Name, if applicable
Is there a Deviation / Variation in use of funds raised No
If yes, whether the same is pursuant to change in terms of a contract or objects, which was approved by the shareholders
If Yes, Date of shareholder Approval
Explanation for the Deviation / Variation
Comments of the Audit Committee after review No Comments
Comments of the auditors, if any No Comments
Sr. Original Object Modified Object, if any Original Allocation Modified allocation, if any Funds Utilised Amount of Deviation/Variation for the quarter according to applicable object Remarks if any
1 Augmentation of capital base to maintain and strengthen solvency levels Not Applicable 8000000000 0 7951601000 0 The Company raised funds through Public issue on November 12 2024. During the quarter ended March 2025 there was no fund raising in any manner.


Signatory Details
Name of signatory Vishwanath Mahendra
Designation of person Chief Financial Officer
Place New Delhi
Date 07-May-2025




Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)
Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity /subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
Total value of transaction during the reporting period





Format for Disclosing Outstanding Default on Loans and Debt Securities
Sr. No. Particulars Amount Remarks
1. Loans / revolving facilities like cash credit from banks / financial institutions
A Total amount outstanding as on date
B Of the total amount outstanding, amount of default as on date
2. Unlisted debt securities i.e. NCDs and NCRPS
A Total amount outstanding as on date
B Of the total amount outstanding, amount of default as on date
3. Total financial indebtedness of the listed entity including short-term and long-term debt